Immunological mechanisms in the pathogenesis of diabetic retinopathy
- 14 March 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Seminars in Immunopathology
- Vol. 30 (2), 65-84
- https://doi.org/10.1007/s00281-008-0111-x
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- Triamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakageLife Sciences, 2007
- The effect of long-term treatment with sulindac on the progression of diabetic retinopathy*Current Medical Research and Opinion, 2007
- Hereditary angioedemaCurrent Opinion in Hematology, 2005
- Vitreous Levels of Vascular Endothelial Growth Factor and Intercellular Adhesion Molecule 1 Are Related to Diabetic Macular EdemaOphthalmology, 2005
- Inhibitors of Ocular NeovascularizationJama-Journal Of The American Medical Association, 2005
- Vascular Endothelial Growth Factor Reduced and Connective Tissue Growth Factor Induced by Triamcinolone in ARPE19 Cells under Oxidative StressInvestigative Ophthalmology & Visual Science, 2005
- A central role for inflammation in the pathogenesis of diabetic retinopathyThe FASEB Journal, 2004
- Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppressionThe FASEB Journal, 2002
- An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphismHuman Immunology, 1996
- DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITISThe Lancet, 1964